摘要
目的探究阿达木单抗致结核的一般规律和特点,为临床合理安全使用阿达木单抗提供参考。方法检索中国知网、万方、维普和Pubmed数据库截至2018年7月31日发表的使用阿达木单抗出现结核的文献,依据纳入与排除标准对文献资料进行提取与统计分析。结果共纳入39篇文献,共39例病例。男性患者与女性患者数量基本相当,40岁以上患者占比最多(79.49%),原患疾病主要为类风湿关节炎(41.02%),用药前结核筛查率为97.44%,肺外结核发生率为53.85%,94.87%的患者结核发病时间在用药后3年内,1例患者(2.56%)治疗无效死亡。结论加强对医务人员对阿达木单抗增加结核风险的关注,制定合理的随访计划,确保用药安全。
Objective To investigate the characteristics and patterns of tuberculosis induced by adalimumab,to find its risk factors and provide technical support for safe and rational use of drugs in clinic.Methods Literatures of tuberculosis induced by adalimumab published until July 2018 were retrieved from CNKI,Wanfang database,VIP Chinese full-text database and Pubmed.According to inclusion and exclusion criteria,the literatures were analyzed.Results A total of 39 papers,39 cases were included.The proportion of tuberculosis occurring in men was almost the same as women.Patients aged over 40 years old had the highest percentage(79.49%),and the primary disease was rheumatoid arthritis(41.02%).The rate of tuberculosis screening before medication was 97.44%.The incidence of extrapulmonary tuberculosis was 53.85%.94.87% patients suffered tuberculosis within 3 years after drug use.One patient(2.56%)died.Conclusion Attention of medical staff should be paid to the risk of tuberculosis induced by adalimumab,and the rational follow-up should be made to ensure the safe drug use in clinic.
作者
蔡俊
卫菁
纪立伟
CAI Jun;WEI Jing;JI Liwei(Department of Pharmacy,Nanjing Drum Tower Hospital Affiliated to Medical College of Nanjing University,Jiangsu Nanjing 210008,China;Jiangsu Province Hospital of TCM Affiliated to Nanjing University of Chinese Medicine,Jiangsu Nanjing 210029,China;Beijing Hospital,National Center of Gerontology,Beijing 100730,China)
出处
《中国药物警戒》
2018年第11期682-685,共4页
Chinese Journal of Pharmacovigilance
关键词
阿达木单抗
结核
文献分析
adalimumab
tuberculosis
literature analysis
